HITI
High Tide Inc.
NASDAQ · Healthcare · Medical - Pharmaceuticals · CA
$2.57
+1.79%Year over year
Reported trailing growth
- Revenue
- +22.1%
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- +7.5%
- Operating cash flow
- +1.7%
Forward estimates
Based on analyst estimates
- Revenue
- +19.3%
- EBITDA
- +2203.0%
- EPS
- +132.7%
Three-year CAGR
- Revenue
- +18.5%
- EBITDA
- —
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- -4.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Apr 1, 2026